Patent Law And Generic Drug Substitution Cases in Federal Circuit

Browse 1 patent law and generic drug substitution cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Defendant Win

Patent Law And Generic Drug Substitution Opinions from Federal Circuit (1)

Merck Sharp & Dohme B v. v. Aurobindo Pharma USA, Inc.

Federal Circuit Upholds Merck's Januvia Patent Against Obviousness Challenge

Federal Circuit · 2025-03-13 · Defendant Win · Impact: 75/100

Merck Sharp & Dohme B v. v. Aurobindo Pharma USA, Inc., decided by Federal Circuit on March 13, 2025, resulted in a defendant win outcome. The core dispute centered on whether Merck's patent for its b...

Frequently Asked Questions

Q: How many patent law and generic drug substitution cases has Federal Circuit decided?

CaseLawBrief currently tracks 1 patent law and generic drug substitution cases from Federal Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in patent law and generic drug substitution cases at Federal Circuit?

Outcome breakdown: Defendant Win: 1.

Q: Where can I find plain English summaries of patent law and generic drug substitution rulings from Federal Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All Federal Circuit Cases All Patent Law And Generic Drug Substitution Cases All Courts All Topics Search